Measuring therapeutic efficacy in patients with Alzheimer’s disease: role of instruments
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Dementia and Geriatric Cognitive Disorders ; 31 (2011), 3. - S. 233-238. - ISSN 1420-8008. - eISSN 1421-9824
- Schlagwort
-
Alzheimerkrankheit
Therapie
Kognition
Metaanalyse
- Ereignis
-
Veröffentlichung
- (wo)
-
Ulm
- (wer)
-
Universität Ulm
- (wann)
-
2011
- Urheber
-
Riepe, Matthias W.
Janetzky, Wolfgang
Lemming, Ole M.
- DOI
-
10.18725/OPARU-40131
- URN
-
urn:nbn:de:bsz:289-oparu-40207-1
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:47 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Riepe, Matthias W.
- Janetzky, Wolfgang
- Lemming, Ole M.
- Universität Ulm
Entstanden
- 2011
Ähnliche Objekte (12)
Alzheimer disease : therapeutic strategies
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Alzheimer's disease - pathomechanisms and novel therapeutic strategies
Alzheimer's disease
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Measuring compounds in exhaled air to detect Alzheimer´s disease and Parkinson´s disease
Microglial Activation in Alzheimer’s Disease
Toward a precision medicine in Alzheimer’s Disease: blood phenomic fingerprint for diagnostic and therapeutic developments
Immunology and Alzheimer's disease
Genetics and Alzheimer's disease
Neurophilosophy and Alzheimer's disease
Heterogeneity of Alzheimer's disease
Alzheimer disease : therapeutic strategies
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Alzheimer's disease - pathomechanisms and novel therapeutic strategies
Alzheimer's disease
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Measuring compounds in exhaled air to detect Alzheimer´s disease and Parkinson´s disease
Microglial Activation in Alzheimer’s Disease
Toward a precision medicine in Alzheimer’s Disease: blood phenomic fingerprint for diagnostic and therapeutic developments
Immunology and Alzheimer's disease
Genetics and Alzheimer's disease
Neurophilosophy and Alzheimer's disease
Heterogeneity of Alzheimer's disease
Alzheimer disease : therapeutic strategies
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Alzheimer's disease - pathomechanisms and novel therapeutic strategies
Alzheimer's disease
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Measuring compounds in exhaled air to detect Alzheimer´s disease and Parkinson´s disease
Microglial Activation in Alzheimer’s Disease
Toward a precision medicine in Alzheimer’s Disease: blood phenomic fingerprint for diagnostic and therapeutic developments
Immunology and Alzheimer's disease
Genetics and Alzheimer's disease
Neurophilosophy and Alzheimer's disease